相关实验视频
Updated: Jul 4, 2025

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.5K
克洛斯特菌:利用瘤坏死来向基因传递
Jan Theys1, Adam V Patterson2,3, Alexandra M Mowday4,5
1M-Lab, Department of Precision Medicine, GROW - School of Oncology and Reproduction, Maastricht University, 6229 ER, Maastricht, The Netherlands.
Molecular diagnosis & therapy
|February 1, 2024
概括
克洛斯特里菌的目标是固体瘤.
科学领域:
- 型细菌是一种型细菌.
- 癌症基因治疗的基因疗法
- 瘤微环境是一个微环境.
背景情况:
- 固体瘤中的亡在健康组织中是不存在的,提供了治疗点.
- 像Clostridium这样的无氧细菌可以殖民死瘤区域.
- 基于Clostridium的疗法显示出希望,但需要加强有效性.
研究的目的:
- 探索Clostridium作为一种瘤选择性基因传递系统.
- 为了调查Clostridium导向的酶前药疗法.
- 在癌症免疫疗法和免疫调节中评估Clostridium.
主要方法:
- 使用像CRISPR-cas9.9这样的技术对Clostridium进行基因改造.
- 工程Clostridium表达前药物激活酶.
- 开发Clostridium菌株以表达免疫调节分子 (例如IL-2,TNF-α).
主要成果:
- 克洛斯特里可以被设计为稳定的转基因表达.
- 通过Clostridium导向的酶前药疗法实现瘤特异性药物激活.
- 具有局部免疫治疗的潜力,系统毒性降低.
结论:
- 克洛斯特里物种为向癌症治疗提供了一个多功能平台.
- 工程化Clostridium使瘤内的局部基因传递和免疫调节成为可能.
- 基因工程和成像学的进步支持Clostridium的临床进展.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K

